Malin Life Sciences Holdings Ltd - Nov 24, 2021 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Signature
/s/ Pat Jennings, Chief Financial Officer
Stock symbol
PSTX
Transactions as of
Nov 24, 2021
Transactions value $
$268,962
Form type
4
Date filed
11/29/2021, 06:55 PM
Previous filing
Nov 23, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX COMMON STOCK Purchase $7.26K +1.05K +0.01% $6.89 9.59M Nov 24, 2021 Direct F1
transaction PSTX COMMON STOCK Purchase $185K +27.3K +0.28% $6.81 9.62M Nov 26, 2021 Direct F1
transaction PSTX COMMON STOCK Purchase $76.2K +11.1K +0.11% $6.89 9.63M Nov 29, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported prices in Column 4 are weighted average prices. Those shares were purchased in multiple transactions at per share prices ranging from $6.82 to $6.90 on 11/24/2021; $6.66 to $6.90 on 11/26/2021; and $6.86 to $6.90 on 11/29/2021. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.